Otonomy Inc. (OTIC) NASDAQ

$1.87 -0.11 (-5.56%)

Market Cap: $106.44M

As of 05/18/22 04:30 PM EDT. Market closed.

(OTIC)

Otonomy Inc. (OTIC) NASDAQ

$1.87 -0.11 (-5.56%)

Market Cap: $106.44M

As of 05/18/22 04:30 PM EDT. Market closed.

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products ... read more

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
David Weber
Full Time Employees
56
CEO Compensation (Base)
$530,000
CEO Compensation (Total)
$2.44M
URL
Address
4796 Executive Dr, California, San Diego, 92121-3090.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
David Weber
Full Time Employees
56
CEO Compensation (Base)
$530,000
CEO Compensation (Total)
$2.44M
Address
4796 Executive Dr, California, San Diego, 92121-3090.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$1.98
Days Range
$1.85 - $2.11
52 week range
$1.14 - $2.59
Volume
133,803
Avg. Volume (30 days)
187,668
Market Cap
$106.44M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,921,605
Open
$0
Previous Close
$1.98
Days Range
$1.85 - $2.11
52 week range
$1.14 - $2.59
Volume
133,803
Avg. Volume (30 days)
187,668
Market Cap
$106.44M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,921,605

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OTONOMY INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Weber David Allen President & CEO Mar 28, 2022 Sale $2.41 11,243 27,129 377,499 Mar 29, 2022, 08:59 PM
Weber David Allen President & CEO Mar 25, 2022 Sale $2.39 8,026 19,166 388,742 Mar 29, 2022, 08:59 PM
Savel Robert Michael II Chief Technical Officer Mar 25, 2022 Sale $2.39 2,374 5,669 149,060 Mar 29, 2022, 08:58 PM
Savel Robert Michael II Chief Technical Officer Mar 28, 2022 Sale $2.41 3,325 8,023 145,735 Mar 29, 2022, 08:58 PM
Foster Alan Charles Chief Scientific Officer Mar 28, 2022 Sale $2.41 2,559 6,175 177,017 Mar 29, 2022, 08:54 PM
Foster Alan Charles Chief Scientific Officer Mar 25, 2022 Sale $2.39 1,827 4,363 179,576 Mar 29, 2022, 08:54 PM
Cayer Paul E Ch. Financial & Business Offcr Mar 25, 2022 Sale $2.39 4,015 9,588 229,411 Mar 29, 2022, 08:53 PM
Cayer Paul E Ch. Financial & Business Offcr Mar 28, 2022 Sale $2.41 5,624 13,571 223,787 Mar 29, 2022, 08:53 PM
Lichter Jay Director Mar 03, 2021 Sale $2.70 321,180 866,544 0 Mar 03, 2021, 08:06 PM
Lichter Jay Director Mar 02, 2021 Sale $2.90 389,574 1,129,375 207,245 Mar 02, 2021, 07:51 PM
Lichter Jay Director Mar 01, 2021 Sale $2.86 173,700 496,087 458,620 Mar 02, 2021, 07:51 PM
Lichter Jay Director Feb 26, 2021 Sale $2.83 330,554 935,468 570,701 Mar 02, 2021, 07:51 PM
Lichter Jay Director Feb 25, 2021 Sale $2.95 311,100 918,989 783,993 Feb 25, 2021, 09:56 PM
Lichter Jay Director Feb 24, 2021 Sale $2.98 503,135 1,500,349 984,732 Feb 25, 2021, 09:56 PM
Lichter Jay Director Feb 23, 2021 Sale $2.89 268,118 774,325 1,309,383 Feb 25, 2021, 09:56 PM
Lichter Jay Director Aug 31, 2017 Option Exercise $18.37 108,851 1,999,593 2,297,361 Sep 05, 2017, 06:38 PM
Lichter Jay Director Aug 31, 2017 Option Exercise $14.18 141,060 2,000,231 2,406,212 Sep 05, 2017, 06:38 PM
LOUMEAU ERIC J GC & Chief Compliance Officer Jun 01, 2017 Option Exercise $11.43 1,206 13,785 3,522 Jun 27, 2017, 05:09 PM
LOUMEAU ERIC J GC & Chief Compliance Officer Dec 01, 2016 Option Exercise $13.05 647 8,443 2,316 Jun 27, 2017, 05:09 PM
LOUMEAU ERIC J GC & Chief Compliance Officer Jun 01, 2016 Option Exercise $13.13 1,021 13,406 1,669 Jun 27, 2017, 05:09 PM
LOUMEAU ERIC J GC & Chief Compliance Officer Dec 01, 2015 Option Exercise $20.37 648 13,200 648 Jun 27, 2017, 05:09 PM
LOUMEAU ERIC J GC & Chief Compliance Officer Jun 26, 2017 Sale $18.75 1,206 22,613 0 Jun 27, 2017, 05:09 PM
LOUMEAU ERIC J GC & Chief Compliance Officer Jun 23, 2017 Sale $18.50 2,316 42,846 1,206 Jun 27, 2017, 05:09 PM
LeBel Carl Chief Scientific Officer Nov 21, 2016 Option Exercise $3.17 1,456 4,616 10,914 Nov 22, 2016, 05:57 PM
LeBel Carl Chief Scientific Officer Nov 18, 2016 Option Exercise $4.39 9,169 40,262 18,627 Nov 22, 2016, 05:57 PM
LeBel Carl Chief Scientific Officer Nov 21, 2016 Sale $18.07 1,456 26,303 9,458 Nov 22, 2016, 05:57 PM
LeBel Carl Chief Scientific Officer Nov 18, 2016 Sale $18.07 9,169 165,703 9,458 Nov 22, 2016, 05:57 PM
LeBel Carl Chief Scientific Officer Jun 01, 2016 Option Exercise $13.13 275 3,611 9,458 Sep 08, 2016, 06:55 PM
LeBel Carl Chief Scientific Officer Dec 01, 2015 Option Exercise $13.60 263 3,577 9,183 Sep 08, 2016, 06:55 PM
LeBel Carl Chief Scientific Officer Sep 06, 2016 Option Exercise $5.54 21,250 117,752 30,708 Sep 08, 2016, 06:55 PM
LeBel Carl Chief Scientific Officer Sep 06, 2016 Sale $17.95 21,250 381,438 18,575 Sep 08, 2016, 06:55 PM
LeBel Carl Chief Scientific Officer Dec 21, 2015 Option Exercise $5.63 21,250 119,743 30,170 Dec 22, 2015, 06:23 PM
LeBel Carl Chief Scientific Officer Dec 21, 2015 Sale $28.04 21,250 595,827 16,981 Dec 22, 2015, 06:23 PM
Cayer Paul E Ch. Financial & Business Offcr Dec 17, 2015 Option Exercise $6.33 3,000 18,990 12,610 Dec 18, 2015, 08:00 PM
Cayer Paul E Ch. Financial & Business Offcr Dec 17, 2015 Sale $29.70 3,000 89,101 9,910 Dec 18, 2015, 08:00 PM
Weber David Allen President & CEO Dec 15, 2015 Option Exercise $1.76 5,208 9,166 22,811 Dec 16, 2015, 06:34 PM
Weber David Allen President & CEO Dec 15, 2015 Sale $27.25 5,208 141,917 17,603 Dec 16, 2015, 06:34 PM
Savel Robert Michael II Chief Technical Officer Dec 14, 2015 Option Exercise $4.88 5,000 24,393 6,256 Dec 16, 2015, 06:32 PM
Savel Robert Michael II Chief Technical Officer Dec 14, 2015 Sale $26.00 5,000 129,976 3,934 Dec 16, 2015, 06:32 PM
ORBIMED ADVISORS LLC Director Nov 27, 2015 Sale $28.97 29,000 840,130 1,853,400 Nov 30, 2015, 06:55 PM
ORBIMED ADVISORS LLC Director Nov 25, 2015 Sale $28.91 34,800 1,006,068 1,882,400 Nov 30, 2015, 06:55 PM
ORBIMED ADVISORS LLC Director Nov 30, 2015 Sale $28.74 3,306 95,026 1,850,684 Nov 30, 2015, 06:55 PM
Khuong Chau Quang Director Nov 30, 2015 Sale $28.74 3,306 95,026 1,850,684 Nov 30, 2015, 06:50 PM
Khuong Chau Quang Director Nov 27, 2015 Sale $28.97 29,000 840,130 1,853,400 Nov 30, 2015, 06:50 PM
Khuong Chau Quang Director Nov 25, 2015 Sale $28.91 34,800 1,006,068 1,882,400 Nov 30, 2015, 06:50 PM
Khuong Chau Quang Director Nov 23, 2015 Sale $28.45 80,800 2,298,760 1,953,300 Nov 24, 2015, 08:37 PM
Khuong Chau Quang Director Nov 20, 2015 Sale $28.59 83,900 2,398,701 2,034,100 Nov 24, 2015, 08:37 PM
Khuong Chau Quang Director Nov 24, 2015 Sale $28.75 36,100 1,037,875 1,917,200 Nov 24, 2015, 08:37 PM
ORBIMED ADVISORS LLC Director Nov 24, 2015 Sale $28.75 36,100 1,037,875 1,917,200 Nov 24, 2015, 08:31 PM
ORBIMED ADVISORS LLC Director Nov 23, 2015 Sale $28.45 80,800 2,298,760 1,953,300 Nov 24, 2015, 08:31 PM
ORBIMED ADVISORS LLC Director Nov 20, 2015 Sale $28.59 83,900 2,398,701 2,034,100 Nov 24, 2015, 08:31 PM
ORBIMED ADVISORS LLC Director Nov 19, 2015 Sale $28.60 127,300 3,640,780 2,118,000 Nov 19, 2015, 08:39 PM
ORBIMED ADVISORS LLC Director Nov 17, 2015 Sale $28.81 11,098 319,680 2,245,500 Nov 19, 2015, 08:39 PM
Khuong Chau Quang Director Nov 19, 2015 Sale $28.60 127,300 3,640,780 2,118,000 Nov 19, 2015, 08:32 PM
Khuong Chau Quang Director Nov 17, 2015 Sale $28.81 11,098 319,680 2,245,500 Nov 19, 2015, 08:32 PM
Cayer Paul E Ch. Financial & Business Offcr Nov 17, 2015 Option Exercise $6.33 3,000 18,990 12,610 Nov 17, 2015, 08:09 PM
Cayer Paul E Ch. Financial & Business Offcr Nov 17, 2015 Sale $28.69 3,000 86,057 9,610 Nov 17, 2015, 08:09 PM
Weber David Allen President & CEO Nov 16, 2015 Option Exercise $1.76 5,208 9,166 22,811 Nov 17, 2015, 08:08 PM
Weber David Allen President & CEO Nov 16, 2015 Sale $28.57 5,208 148,812 17,703 Nov 17, 2015, 08:08 PM
Weber David Allen President & CEO Nov 13, 2015 Option Exercise $1.76 10,416 18,332 10,955 Nov 13, 2015, 07:59 PM
Weber David Allen President & CEO Nov 13, 2015 Sale $30.95 10,416 322,375 539 Nov 13, 2015, 07:59 PM
Cayer Paul E CFO/Ch. Business Offcr & Sec. Nov 11, 2015 Option Exercise $4.12 3,000 12,350 12,610 Nov 12, 2015, 08:46 PM
Cayer Paul E CFO/Ch. Business Offcr & Sec. Nov 11, 2015 Sale $24.95 3,000 74,850 9,610 Nov 12, 2015, 08:46 PM
Weber David Allen President & CEO Nov 11, 2015 Option Exercise $1.76 5,208 9,166 5,747 Nov 12, 2015, 08:45 PM
Weber David Allen President & CEO Nov 11, 2015 Sale $24.95 5,208 129,940 539 Nov 12, 2015, 08:45 PM
LeBel Carl Chief Scientific Officer Sep 21, 2015 Option Exercise $5.43 21,250 115,469 30,170 Sep 22, 2015, 07:01 PM
LeBel Carl Chief Scientific Officer Sep 21, 2015 Sale $24.36 21,250 517,576 8,920 Sep 22, 2015, 07:01 PM
Cayer Paul E CFO/Ch. Business Offcr & Sec. Sep 17, 2015 Option Exercise $1.76 3,000 5,280 12,610 Sep 18, 2015, 07:05 PM
Cayer Paul E CFO/Ch. Business Offcr & Sec. Sep 17, 2015 Sale $24.95 3,000 74,850 9,610 Sep 18, 2015, 07:05 PM
Weber David Allen President & CEO Sep 15, 2015 Option Exercise $1.76 5,216 9,180 5,755 Sep 16, 2015, 05:17 PM
Weber David Allen President & CEO Sep 15, 2015 Sale $24.95 5,216 130,139 539 Sep 16, 2015, 05:17 PM
Savel Robert Michael II Chief Technical Officer Sep 14, 2015 Option Exercise $4.88 5,000 24,397 6,256 Sep 15, 2015, 05:50 PM
Savel Robert Michael II Chief Technical Officer Sep 14, 2015 Sale $23.98 5,000 119,896 1,256 Sep 15, 2015, 05:50 PM
Savel Robert Michael II Chief Technical Officer Jun 15, 2015 Option Exercise $4.46 25,000 111,581 26,256 Jun 17, 2015, 08:06 PM
Savel Robert Michael II Chief Technical Officer Jun 15, 2015 Sale $23.73 25,000 593,285 1,256 Jun 17, 2015, 08:06 PM
Weber David Allen President & CEO Jun 01, 2015 Option Exercise $13.60 539 7,330 539 Jun 02, 2015, 09:01 PM
Savel Robert Michael II Chief Technical Officer Jun 01, 2015 Option Exercise $13.60 1,256 17,082 1,256 Jun 02, 2015, 08:59 PM
LeBel Carl Chief Scientific Officer Jun 01, 2015 Option Exercise $13.60 389 5,290 389 Jun 02, 2015, 08:58 PM
Cayer Paul E CFO/Ch. Business Offcr & Sec. Jun 01, 2015 Option Exercise $13.60 2,500 34,000 2,500 Jun 02, 2015, 08:57 PM
CAPPS VICKIE L Director May 22, 2015 Buy $24.35 1,600 38,960 1,600 May 27, 2015, 05:16 PM
CAPPS VICKIE L Director May 22, 2015 Buy $24.36 3,400 82,808 3,400 May 27, 2015, 05:16 PM
Novo A/S 10% Owner Aug 19, 2014 Buy $15.50 15,690 243,135 2,175,025 Aug 21, 2014, 05:15 PM
MCKEARN JOHN P Director Aug 18, 2014 Sale $8.79 25,000 219,750 794,177 Aug 19, 2014, 07:35 PM
MCKEARN JOHN P Director Aug 18, 2014 Option Exercise $8.79 45,505 399,989 813,837 Aug 19, 2014, 07:35 PM
Avalon Ventures VIII LP 10% Owner Aug 18, 2014 Buy $16.00 109,375 1,750,000 814,973 Aug 19, 2014, 07:34 PM
Avalon Ventures VIII LP 10% Owner Aug 18, 2014 Sale $16.00 50,001 800,016 1,450,179 Aug 19, 2014, 07:34 PM
Avalon Ventures VIII LP 10% Owner Aug 18, 2014 Option Exercise $8.79 91,011 799,987 1,500,180 Aug 19, 2014, 07:34 PM
Weber David Allen President & CEO Aug 18, 2014 Option Exercise $8.79 113 993 4,812 Aug 19, 2014, 07:31 PM
ORBIMED ADVISORS LLC 10% Owner Aug 18, 2014 Buy $16.00 171,875 2,750,000 2,256,398 Aug 19, 2014, 07:30 PM
Khuong Chau Quang Director Aug 18, 2014 Buy $16.00 171,875 2,750,000 2,256,398 Aug 19, 2014, 07:29 PM
Lichter Jay Director Aug 18, 2014 Buy $16.00 109,375 1,750,000 814,973 Aug 19, 2014, 07:27 PM
Lichter Jay Director Aug 18, 2014 Sale $16.00 50,001 800,016 1,450,179 Aug 19, 2014, 07:27 PM
Lichter Jay Director Aug 18, 2014 Option Exercise $8.79 91,011 799,987 1,500,180 Aug 19, 2014, 07:27 PM
Novo A/S 10% Owner Aug 18, 2014 Buy $16.00 171,875 2,750,000 2,159,335 Aug 19, 2014, 04:52 PM
DP VIII Associates, L.P. 10% Owner Aug 18, 2014 Option Exercise $16.00 277 4,432 11,715 Aug 18, 2014, 05:37 PM
DP VIII Associates, L.P. 10% Owner Aug 18, 2014 Option Exercise $8.79 502 4,413 11,992 Aug 18, 2014, 05:37 PM
Domain Partners VIII, L.P. 10% Owner Aug 18, 2014 Option Exercise $16.00 37,224 595,584 1,579,323 Aug 18, 2014, 05:29 PM
Domain Partners VIII, L.P. 10% Owner Aug 18, 2014 Option Exercise $8.79 67,755 595,566 1,616,547 Aug 18, 2014, 05:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Weber David Allen President & CEO 03/28/2022 27,129
Weber David Allen President & CEO 03/25/2022 19,166
Savel Robert Michael II Chief Technical Officer 03/25/2022 5,669
Savel Robert Michael II Chief Technical Officer 03/28/2022 8,023
Foster Alan Charles Chief Scientific Officer 03/28/2022 6,175
Foster Alan Charles Chief Scientific Officer 03/25/2022 4,363
Cayer Paul E Ch. Financial & Business Offcr 03/25/2022 9,588
Cayer Paul E Ch. Financial & Business Offcr 03/28/2022 13,571
Lichter Jay Director 03/03/2021 866,544
Lichter Jay Director 03/02/2021 1,129,375
Lichter Jay Director 03/01/2021 496,087
Lichter Jay Director 02/26/2021 935,468
Lichter Jay Director 02/25/2021 918,989
Lichter Jay Director 02/24/2021 1,500,349
Lichter Jay Director 02/23/2021 774,325
Lichter Jay Director 08/31/2017 1,999,593
Lichter Jay Director 08/31/2017 2,000,231
LOUMEAU ERIC J GC & Chief Compliance Officer 06/01/2017 13,785
LOUMEAU ERIC J GC & Chief Compliance Officer 12/01/2016 8,443
LOUMEAU ERIC J GC & Chief Compliance Officer 06/01/2016 13,406
LOUMEAU ERIC J GC & Chief Compliance Officer 12/01/2015 13,200
LOUMEAU ERIC J GC & Chief Compliance Officer 06/26/2017 22,613
LOUMEAU ERIC J GC & Chief Compliance Officer 06/23/2017 42,846
LeBel Carl Chief Scientific Officer 11/21/2016 4,616
LeBel Carl Chief Scientific Officer 11/18/2016 40,262
LeBel Carl Chief Scientific Officer 11/21/2016 26,303
LeBel Carl Chief Scientific Officer 11/18/2016 165,703
LeBel Carl Chief Scientific Officer 06/01/2016 3,611
LeBel Carl Chief Scientific Officer 12/01/2015 3,577
LeBel Carl Chief Scientific Officer 09/06/2016 117,752
LeBel Carl Chief Scientific Officer 09/06/2016 381,438
LeBel Carl Chief Scientific Officer 12/21/2015 119,743
LeBel Carl Chief Scientific Officer 12/21/2015 595,827
Cayer Paul E Ch. Financial & Business Offcr 12/17/2015 18,990
Cayer Paul E Ch. Financial & Business Offcr 12/17/2015 89,101
Weber David Allen President & CEO 12/15/2015 9,166
Weber David Allen President & CEO 12/15/2015 141,917
Savel Robert Michael II Chief Technical Officer 12/14/2015 24,393
Savel Robert Michael II Chief Technical Officer 12/14/2015 129,976
ORBIMED ADVISORS LLC Director 11/27/2015 840,130
ORBIMED ADVISORS LLC Director 11/25/2015 1,006,068
ORBIMED ADVISORS LLC Director 11/30/2015 95,026
Khuong Chau Quang Director 11/30/2015 95,026
Khuong Chau Quang Director 11/27/2015 840,130
Khuong Chau Quang Director 11/25/2015 1,006,068
Khuong Chau Quang Director 11/23/2015 2,298,760
Khuong Chau Quang Director 11/20/2015 2,398,701
Khuong Chau Quang Director 11/24/2015 1,037,875
ORBIMED ADVISORS LLC Director 11/24/2015 1,037,875
ORBIMED ADVISORS LLC Director 11/23/2015 2,298,760
ORBIMED ADVISORS LLC Director 11/20/2015 2,398,701
ORBIMED ADVISORS LLC Director 11/19/2015 3,640,780
ORBIMED ADVISORS LLC Director 11/17/2015 319,680
Khuong Chau Quang Director 11/19/2015 3,640,780
Khuong Chau Quang Director 11/17/2015 319,680
Cayer Paul E Ch. Financial & Business Offcr 11/17/2015 18,990
Cayer Paul E Ch. Financial & Business Offcr 11/17/2015 86,057
Weber David Allen President & CEO 11/16/2015 9,166
Weber David Allen President & CEO 11/16/2015 148,812
Weber David Allen President & CEO 11/13/2015 18,332
Weber David Allen President & CEO 11/13/2015 322,375
Cayer Paul E CFO/Ch. Business Offcr & Sec. 11/11/2015 12,350
Cayer Paul E CFO/Ch. Business Offcr & Sec. 11/11/2015 74,850
Weber David Allen President & CEO 11/11/2015 9,166
Weber David Allen President & CEO 11/11/2015 129,940
LeBel Carl Chief Scientific Officer 09/21/2015 115,469
LeBel Carl Chief Scientific Officer 09/21/2015 517,576
Cayer Paul E CFO/Ch. Business Offcr & Sec. 09/17/2015 5,280
Cayer Paul E CFO/Ch. Business Offcr & Sec. 09/17/2015 74,850
Weber David Allen President & CEO 09/15/2015 9,180
Weber David Allen President & CEO 09/15/2015 130,139
Savel Robert Michael II Chief Technical Officer 09/14/2015 24,397
Savel Robert Michael II Chief Technical Officer 09/14/2015 119,896
Savel Robert Michael II Chief Technical Officer 06/15/2015 111,581
Savel Robert Michael II Chief Technical Officer 06/15/2015 593,285
Weber David Allen President & CEO 06/01/2015 7,330
Savel Robert Michael II Chief Technical Officer 06/01/2015 17,082
LeBel Carl Chief Scientific Officer 06/01/2015 5,290
Cayer Paul E CFO/Ch. Business Offcr & Sec. 06/01/2015 34,000
CAPPS VICKIE L Director 05/22/2015 38,960
CAPPS VICKIE L Director 05/22/2015 82,808
Novo A/S 10% Owner 08/19/2014 243,135
MCKEARN JOHN P Director 08/18/2014 219,750
MCKEARN JOHN P Director 08/18/2014 399,989
Avalon Ventures VIII LP 10% Owner 08/18/2014 1,750,000
Avalon Ventures VIII LP 10% Owner 08/18/2014 800,016
Avalon Ventures VIII LP 10% Owner 08/18/2014 799,987
Weber David Allen President & CEO 08/18/2014 993
ORBIMED ADVISORS LLC 10% Owner 08/18/2014 2,750,000
Khuong Chau Quang Director 08/18/2014 2,750,000
Lichter Jay Director 08/18/2014 1,750,000
Lichter Jay Director 08/18/2014 800,016
Lichter Jay Director 08/18/2014 799,987
Novo A/S 10% Owner 08/18/2014 2,750,000
DP VIII Associates, L.P. 10% Owner 08/18/2014 4,432
DP VIII Associates, L.P. 10% Owner 08/18/2014 4,413
Domain Partners VIII, L.P. 10% Owner 08/18/2014 595,584
Domain Partners VIII, L.P. 10% Owner 08/18/2014 595,566
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2021
03/31/2021
12.79%
1Q

Period of Report: 06/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
12.79%
1Q